Home Page - Food and Drug Administration
Source: https://www.fda.gov.ph
Archived: 2026-04-23 15:19
Home Page - Food and Drug Administration
Close
Menu
Philippine Standard Time
Philippine Standard Time
--:--:--
--
Philippine Standard Time
Philippine Standard Time
--:--:--
--
Menu
May 2025 Banner
January 2023 Banner
MicrosoftTeams-image (5)
MORE
Slide
Slide
Slide 1
Learn More
IEC
MORE
Services
Image Click Redirect - Container 1
Click to start
For Applications Involving Cosmetics and Household /
Urban
Hazardous Substances and Toys and Child Care Articles and Establishments
Image Click Redirect - Container 2
Click to start
For Applications Involving Pre-Packaged Food Products and Establishments
Image Click Redirect - Container 3
Click to start
For Applications Involving Medical and Radiation Emitting Devices and Establishments
Image Click Redirect - Container 4
Click to start
For Applications Involving Drug Products and Establishments
Reporting and Verification
Announcements
General Announcements
𝐖𝐇𝐄𝐍 𝐓𝐑𝐔𝐒𝐓 𝐈𝐒 𝐓𝐄𝐒𝐓𝐄𝐃: 𝙃𝙊𝙇𝘿𝙄𝙉𝙂 𝙏𝙃𝙀 𝙇𝙄𝙉𝙀 𝙊𝙉 𝙎𝘼𝙁𝙀𝙏𝙔 𝙒𝙃𝙄𝙇𝙀 𝙍𝙀𝙈𝘼𝙄𝙉𝙄𝙉𝙂 𝙃𝙊𝙒 𝘼 𝙉𝘼𝙏𝙄𝙊𝙉 𝙄𝙎 𝙋𝙍𝙊𝙏𝙀𝘾𝙏𝙀𝘿
23 April 2026
In February 2026, the FDA intensified its efforts against unregistered and counterfeit health products circulating online. These products, often lacking...
Read More
General Announcements
𝐁𝐄𝐓𝐖𝐄𝐄𝐍 𝐑𝐈𝐒𝐊𝐒 𝐀𝐍𝐃 𝐑𝐄𝐌𝐄𝐃𝐈𝐄𝐒: 𝘼 𝙎𝙏𝙊𝙍𝙔 𝙊𝙁 𝙑𝙄𝙂𝙄𝙇𝘼𝙉𝘾𝙀, 𝙏𝙍𝙐𝙎𝙏, 𝘼𝙉𝘿 𝙏𝙍𝘼𝙉𝙎𝙁𝙊𝙍𝙈𝘼𝙏𝙄𝙊𝙉
21 April 2026
At the start of the year, the Food and Drug Administration (FDA) remained focused on its mandate to protect public...
Read More
General Announcements
𝐅𝐃𝐀 𝐀𝐍𝐃 𝐒𝐖𝐈𝐒𝐒 𝐂𝐇𝐀𝐌𝐁𝐄𝐑 𝐎𝐅 𝐂𝐎𝐌𝐌𝐄𝐑𝐂𝐄 𝐎𝐅 𝐓𝐇𝐄 𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄𝐒 𝐏𝐎𝐖𝐄𝐑𝐈𝐍𝐆 𝐑𝐄𝐀𝐋 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐂𝐇𝐀𝐍𝐆𝐄
20 April 2026
Makati City—The Food and Drug Administration (FDA), in collaboration with the Swiss Chamber of Commerce of the Philippines (SCCP), convened...
Read More
General Announcements
𝐁𝐑𝐈𝐍𝐆𝐈𝐍𝐆 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑: 𝐅𝐃𝐀 𝐒𝐔𝐏𝐏𝐎𝐑𝐓𝐒 𝐒𝐓𝐀𝐊𝐄𝐇𝐎𝐋𝐃𝐄𝐑𝐒 𝐀𝐍𝐃 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐁𝐈𝐂𝐔𝐓𝐀𝐍, 𝐓𝐀𝐆𝐔𝐈𝐆 𝐂𝐈𝐓𝐘
20 April 2026
Bicutan, Taguig City – On 14 April 2026, the Food and Drug Administration (FDA) participated in the Lab for All...
Read More
General Announcements
𝐅𝐈𝐆𝐔𝐑𝐄𝐒 𝐈𝐍 𝐅𝐎𝐂𝐔𝐒
20 April 2026
𝘞𝘩𝘢𝘵 𝘮𝘢𝘬𝘦𝘴 𝘦𝘷𝘦𝘳𝘺 𝘯𝘶𝘮𝘣𝘦𝘳 𝘤𝘰𝘶𝘯𝘵? The FDA Verification Portal reflects 𝟐,𝟑𝟏𝟑 𝐕𝐀𝐓-𝐞𝐱𝐞𝐦𝐩𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬, capturing real-time updates as entries are...
Read More
General Announcements
𝐅𝐃𝐀 𝐀𝐓 𝐋𝐈𝐏𝐀 𝐁𝐔𝐒𝐈𝐍𝐄𝐒𝐒 𝐅𝐎𝐑𝐔𝐌: 𝐒𝐔𝐏𝐏𝐎𝐑𝐓𝐈𝐍𝐆 𝐌𝐒𝐌𝐄𝐒 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐂𝐎𝐌𝐏𝐋𝐈𝐀𝐍𝐂𝐄
20 April 2026
In line with the commitment of Director General Paolo S. Teston to empower Micro, Small and Medium Enterprises (MSMEs) and...
Read More
General Announcements
𝐒𝐓𝐑𝐈𝐂𝐓 𝐀𝐂𝐓𝐈𝐎𝐍 𝐓𝐀𝐊𝐄𝐍
20 April 2026
𝘏𝘰𝘸 𝘧𝘢𝘳 𝘤𝘢𝘯 𝘦𝘯𝘧𝘰𝘳𝘤𝘦𝘮𝘦𝘯𝘵 𝘨𝘰 𝘸𝘩𝘦𝘯 𝘷𝘪𝘨𝘪𝘭𝘢𝘯𝘤𝘦 𝘭𝘦𝘢𝘥𝘴 𝘵𝘩𝘦 𝘸𝘢𝘺? In the first quarter of 2026, a total of ₱𝟔,𝟔𝟎𝟎,𝟎𝟎𝟎.𝟎𝟎...
Read More
Academy Training Schedule
Training on Good Manufacturing Practice for Food Manufacturers and Traders (GMP-FMT)
20 April 2026
This webinar will provide the methods, identify the equipment, enumerate the facilities, and determine the controls for producing processed food...
Read More
General Announcements
𝐀𝐓 𝐘𝐎𝐔𝐑 𝐒𝐄𝐑𝐕𝐈𝐂𝐄
15 April 2026
𝘏𝘰𝘸 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦 𝘪𝘴 𝘍𝘋𝘈 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘸𝘩𝘦𝘯 𝘪𝘵 𝘮𝘢𝘵𝘵𝘦𝘳𝘴 𝘮𝘰𝘴𝘵? More than you might think. Throughout December 2025 to March 2026,...
Read More
General Announcements
𝐖𝐇𝐄𝐑𝐄 𝐑𝐄𝐅𝐎𝐑𝐌𝐒 𝐁𝐄𝐆𝐈𝐍
15 April 2026
𝘞𝘩𝘢𝘵’𝘴 𝘲𝘶𝘪𝘦𝘵𝘭𝘺 𝘱𝘰𝘸𝘦𝘳𝘪𝘯𝘨 𝘵𝘩𝘦 𝘍𝘋𝘈’𝘴 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯? It’s not just the numbers you see. Behind the scenes, 𝟏𝟓𝟓 𝐬𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫 𝐚𝐧𝐝 𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐚𝐥...
Read More
View More
Latest Advisories
Food Advisories
FDA Advisory No.2026-0434 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION UFC Tropical Punch”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0433 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION Strawberry Watermelon Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0432 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME ICE HYDRATION Red Chill Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0431 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME ICE HYDRATION Orange Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0430 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYRDATION Goalberry”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0429 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION Banana Strawberry”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0428 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “POST MARSHMALLOW FRUITY PEBBLES Sweetened Rice Cereal with Marshmallows Natural & Artificial Fruit Flavors”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0427 || The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the unregistered food supplement below:
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0426 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “DR. PINOCA Premium Healthy Rice Low Calories – Low Carb – No Fat”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0425 || Public Health Warning Against the Purchase and Consumption of the Unregistered Dietary Supplement “MULITTEA Magnesium Gummies Extra Strength Dietary Supplement”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
View More
Latest Issuances
FDA Circular
FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)
16 December 2025
FDA Circular
FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM
16 December 2025
Administrative Order
Drugs Advisories
Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use
26 November 2025
FDA Circular
FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””
4 September 2025
FDA Circular
FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation
14 July 2025
FDA Circular
FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation
3 July 2025
FDA Circular
DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
11 June 2025
FDA Circular
FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings
18 March 2025
FDA Circular
FDA Circular No.2025-001 || Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”
7 January 2025
Administrative Order
Administrative Order No. 2024-0016 || Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration
3 January 2025
View More
Draft for Comments
Draft for Comments
Draft for Comments || Recognition and Adoption of Official Pharmacopeias for the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients for Human Use
8 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 08 May 2026. I....
Read More
Draft for Comments
Draft for Comments || Amendment to Administrative Order No. 2024-0013 Titled “General Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended for Human Use”
7 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 05 June 2026. I....
Read More
Draft for Comments
Draft for Comments || Amendment to Administrative Order No. 2024-0012 Titled “Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended Solely for Export”
7 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 05 June 2026. I....
Read More
Draft for Comments
Draft for Comments || Good Storage and Distribution Practices for Medical Devices
26 March 2026
All comments can be sent at cdrrhr-prsdd@fda.gov.ph. Deadline of submission of comments shall be by 26 April 2026. I. RATIONALE ...
Read More
Draft for Comments
Draft for Comments || Content of License to Operate (LTO) issued by the Food and Drug Administration for Pharmaceutical Establishments
18 March 2026
All comments can be sent at cdrr.sds@fda.gov.ph. Deadline of submission of comments shall be by 24 April 2026. I. RATIONALE...
Read More
Draft for Comments
Draft for Comments || Use of Official Digital Regulatory Platforms for Issuance of Marketing Authorization for Pharmaceutical Products for Human Use
6 March 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 10...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Maintenance of Importation and/or Distribution Records, and the Reporting of Product Complaints, Adverse Events, and Field Safety Corrective Actions for Medical Devices
19 February 2026
All comments can be sent at cdrrhr-prsdd@fda.gov.ph. Deadline of submission of comments shall be by 19 March 2022. I. RATIONALE...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Classification of Deficiencies Observed during the Conduct of Inspection According to Risk, and the Procedure of Compliance of Food Business Operators to the Observed Deficiencies
16 February 2026
All comments can be sent at ojolaurenana@fda.gov.ph. Deadline of submission of comments shall be by March 17, 2026. I. BACKGROUND...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Use of Electronic Services (e-Services) System for the Registration of Processed Food Products Repealing, FDA Circular No. 2020-033 “Procedure for the Use of the Modified Electronic Registration System for Raw Materials and Prepackaged Processed Food Products”
16 February 2026
This draft policy on the FDA e-Services System is an initial working draft and remains subject to ongoing internal review,...
Read More
Draft for Comments
Draft for Comments || Adoption of Codex General Standard for Fruit Juices and Nectars (CXS 247-2005) as Technical Regulation
11 February 2026
All comments shall be sent to gapascual@fda.gov.ph. The deadline for submission of comments is on 03 March 2026. I. RATIONALE In...
Read More
View More
Bids and Awards
ITB and RFQ
SVP(A)-2026-0029-CFRR || Procurement of the Supply and Delivery of Various Collateral Materials for the Celebration of the World Safety Day and Advocacy Campaign (June 2026)
22 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Various Collateral Materials for the Celebration of...
Read More
ITB and RFQ
RFPQ-2026-0027-IMS || Procurement of the “Services of a Certifying Body for the Project: Certification Audit for ISO 9001:2015 Quality Management System (QMS)” of the Food and Drug Administration (FDA))
21 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the "Services of a Certifying Body for the Project: Certification Audit for...
Read More
ITB and RFQ
ITB No. 2026-0019-AFO || Procurement of Security Services for the Food and Drug Administration (FDA) – Alabang Testing and Quality Assurance Laboratory (ATQAL) and Food and Drug Action Center (FDAC) for One (1) Year
21 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Security Services for the Food and Drug Administration (FDA) - Alabang Testing...
Read More
ITB and RFQ
SVP(B)-2026-0020-FDAC || Procurement of Supply, Delivery, and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building
7 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply, Delivery, and Installation of Window Blinds for the FDAC, Cashier, and...
Read More
ITB and RFQ
ITB No. 2026-0007-ICMTD || Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet Service and Telephone Subscription for the Food and Drug Administration (FDA) – One Trium Tower for One (1) Year
6 February 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet...
Read More
ITB and RFQ
SVP(A)-2026-0005-FDA-Academy || Procurement for the supply and delivery of the various Collaterals and Training Materials for the Promotion of FDA Academy Trainings/Seminars
5 February 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the supply and delivery of the various Collaterals and Training Materials for...
Read More
ITB and RFQ
NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
22 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of...
Read More
ITB and RFQ
NP-SVP(A)-2025-0202-FDAC || Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building
18 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the...
Read More
ITB and RFQ
NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps
12 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps...
Read More
ITB and RFQ
NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
12 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
Read More
View More
Featured Event
Play
Previous
Next
View More
Featured Activity
Featured Activities
𝐅𝐃𝐀 𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄𝐒 𝐀𝐃𝐕𝐀𝐍𝐂𝐄𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐒𝐀𝐅𝐄𝐓𝐘 𝐀𝐓 𝐒𝐔𝐁𝐈𝐂 𝐁𝐀𝐘 ‘𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋’ 𝐄𝐕𝐄𝐍𝐓
By Administrator 2
/ 26 February 2026
Subic Bay Freeport Zone – On 24 February 2026, the Food and Drug Administration (FDA) Philippines joined the "Lab for...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒
By Administrator 3
/ 4 September 2025
As part of its continuing advocacy to reach out to communities, the Food and Drug Administration (FDA), in partnership...
Read More
Featured Activities
Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖
By Administrator 3
/ 4 September 2025
Baguio City – On 26 August 2025, the Food and Drug Administration (FDA) actively participated in the Department of...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑
By Administrator 3
/ 4 September 2025
Candon City, Ilocos Sur – The Food and Drug Administration (FDA) took part in the Lab For All caravan...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄
By Administrator 3
/ 4 September 2025
Manila City – On 4 August 2025, FDA Director General Paolo S. Teston welcomed Dr. Jinho Shin and Mr....
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘
By Administrator 3
/ 4 September 2025
San Juan City – Last 26 August 2025, the Food and Drug Administration (FDA) participated in the Lab For...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓
By Administrator 3
/ 4 September 2025
Makati City — The Food and Drug Administration (FDA), through its Director General Paolo S. Teston, reaffirmed its commitment...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒
By Administrator 3
/ 4 September 2025
Quezon City – On 30 July 2025, the Food and Drug Administration (FDA), headed by Director General Paolo S....
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒
By Administrator 3
/ 4 September 2025
Alabang, Muntinlupa – As part of its continuing efforts to strengthen regulatory capacity and laboratory competency, the Food and...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍
By Administrator 3
/ 4 September 2025
Pasay City – In celebration of National MSME Week 2025, with the theme “Asenso Negosyo, Angat Kabuhayan: Bagong Pilipinas,”...
Read More
View More
Featured Video
Play
Play
Play
Play
Play
Play
Play
Play
Play
Play
Play
Previous
Next
Press Statements
Press Statement
𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐉𝐀𝐏𝐀𝐍 𝐏𝐌𝐃𝐀 𝐈𝐍𝐒𝐓𝐈𝐓𝐔𝐓𝐈𝐎𝐍𝐀𝐋𝐈𝐙𝐄 𝐒𝐂𝐈𝐄𝐍𝐂𝐄-𝐁𝐀𝐒𝐄𝐃 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐑𝐄𝐋𝐈𝐀𝐍𝐂𝐄 𝐅𝐑𝐀𝐌𝐄𝐖𝐎𝐑𝐊 𝐔𝐍𝐃𝐄𝐑 𝐁𝐈𝐋𝐀𝐓𝐄𝐑𝐀𝐋 𝐂𝐎𝐎𝐏𝐄𝐑𝐀𝐓𝐈𝐎𝐍 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌
13 February 2026
Manila, Philippines — On 12 February 2026, the Food and Drug Administration Philippines (FDA) and the Pharmaceuticals and Medical Devices...
Read More
Press Statement
PRESS RELEASE || FDA CONDUCTS COORDINATED VERIFICATION VISITS NATIONWIDE TO PROTECT CONSUMERS
6 February 2026
Taguig City - Today, 6 February 2026, the Food and Drug Administration (FDA) conducted coordinated compliance verification visits to selected...
Read More
Press Statement
FDA Press Statement || FDA STATEMENT ON THE VOLUNTARY RECALL OF SELECT INFANT FORMULA PRODUCTS
12 January 2026
The Food and Drug Administration (FDA) informs the public that it is actively overseeing and validating the voluntary recall initiated...
Read More
Press Statement
FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency
3 June 2025
Alabang, Muntinlupa City — The Food and Drug Administration (FDA), following the initiative of Director General Paolo S. Teston,...
Read More
Press Statement
FDA Press Statement || FDA Actively Participates During the 2025 USP Convention
3 June 2025
Washington D.C., U.S.A. — To strengthen its global commitment to pharmaceutical excellence and public health, the Food and Drug...
Read More
Press Statement
FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees
29 May 2025
Quezon City — The Food and Drug Administration (FDA) urges the Department of Health to approve the immediate suspension...
Read More
Press Statement
FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION
15 May 2025
Alabang, Muntinlupa City — May 13, 2025 The Food and Drug Administration (FDA) of the Philippines welcomed its...
Read More
Press Statement
FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar
23 April 2025
The Food and Drug Administration (FDA) actively participated in the 1st Quarter Seminar of the Philippine Association of Pharmacists in...
Read More
Press Statement
FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH
23 April 2025
The Food and Drug Administration (FDA) has actively collaborated with State Universities and Colleges (SUCs) in the Bicol Region...
Read More
Press Statement
FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal
23 April 2025
The Food and Drug Administration (FDA), under the leadership of Director General Dr. Samuel A. Zacate, reaffirmed its continued...
Read More
View More
Quick Links
Contact Information
Department of Health (DOH)
Department of Information and Communications Technology (DICT)
Department of Science and Technology (DOST)
Anti-Red Tape Authority (ARTA)
Address:
Civic Drive Filinvest Corporate City
Alabang, Muntinlupa City
info@fda.gov.ph
Landline:
(02)-8257-1957
(02)-8286-6087
(02)-8273-0481
(02)-8800-4392
(02)-8273-3756
(02)-8659-7330
Copyright ⓒ 2026. All Rights Reserved.
Copyright ⓒ 2026. All Rights Reserved.
Shares
Close
Menu
Philippine Standard Time
Philippine Standard Time
--:--:--
--
Philippine Standard Time
Philippine Standard Time
--:--:--
--
Menu
May 2025 Banner
January 2023 Banner
MicrosoftTeams-image (5)
MORE
Slide
Slide
Slide 1
Learn More
IEC
MORE
Services
Image Click Redirect - Container 1
Click to start
For Applications Involving Cosmetics and Household /
Urban
Hazardous Substances and Toys and Child Care Articles and Establishments
Image Click Redirect - Container 2
Click to start
For Applications Involving Pre-Packaged Food Products and Establishments
Image Click Redirect - Container 3
Click to start
For Applications Involving Medical and Radiation Emitting Devices and Establishments
Image Click Redirect - Container 4
Click to start
For Applications Involving Drug Products and Establishments
Reporting and Verification
Announcements
General Announcements
𝐖𝐇𝐄𝐍 𝐓𝐑𝐔𝐒𝐓 𝐈𝐒 𝐓𝐄𝐒𝐓𝐄𝐃: 𝙃𝙊𝙇𝘿𝙄𝙉𝙂 𝙏𝙃𝙀 𝙇𝙄𝙉𝙀 𝙊𝙉 𝙎𝘼𝙁𝙀𝙏𝙔 𝙒𝙃𝙄𝙇𝙀 𝙍𝙀𝙈𝘼𝙄𝙉𝙄𝙉𝙂 𝙃𝙊𝙒 𝘼 𝙉𝘼𝙏𝙄𝙊𝙉 𝙄𝙎 𝙋𝙍𝙊𝙏𝙀𝘾𝙏𝙀𝘿
23 April 2026
In February 2026, the FDA intensified its efforts against unregistered and counterfeit health products circulating online. These products, often lacking...
Read More
General Announcements
𝐁𝐄𝐓𝐖𝐄𝐄𝐍 𝐑𝐈𝐒𝐊𝐒 𝐀𝐍𝐃 𝐑𝐄𝐌𝐄𝐃𝐈𝐄𝐒: 𝘼 𝙎𝙏𝙊𝙍𝙔 𝙊𝙁 𝙑𝙄𝙂𝙄𝙇𝘼𝙉𝘾𝙀, 𝙏𝙍𝙐𝙎𝙏, 𝘼𝙉𝘿 𝙏𝙍𝘼𝙉𝙎𝙁𝙊𝙍𝙈𝘼𝙏𝙄𝙊𝙉
21 April 2026
At the start of the year, the Food and Drug Administration (FDA) remained focused on its mandate to protect public...
Read More
General Announcements
𝐅𝐃𝐀 𝐀𝐍𝐃 𝐒𝐖𝐈𝐒𝐒 𝐂𝐇𝐀𝐌𝐁𝐄𝐑 𝐎𝐅 𝐂𝐎𝐌𝐌𝐄𝐑𝐂𝐄 𝐎𝐅 𝐓𝐇𝐄 𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄𝐒 𝐏𝐎𝐖𝐄𝐑𝐈𝐍𝐆 𝐑𝐄𝐀𝐋 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐂𝐇𝐀𝐍𝐆𝐄
20 April 2026
Makati City—The Food and Drug Administration (FDA), in collaboration with the Swiss Chamber of Commerce of the Philippines (SCCP), convened...
Read More
General Announcements
𝐁𝐑𝐈𝐍𝐆𝐈𝐍𝐆 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑: 𝐅𝐃𝐀 𝐒𝐔𝐏𝐏𝐎𝐑𝐓𝐒 𝐒𝐓𝐀𝐊𝐄𝐇𝐎𝐋𝐃𝐄𝐑𝐒 𝐀𝐍𝐃 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐁𝐈𝐂𝐔𝐓𝐀𝐍, 𝐓𝐀𝐆𝐔𝐈𝐆 𝐂𝐈𝐓𝐘
20 April 2026
Bicutan, Taguig City – On 14 April 2026, the Food and Drug Administration (FDA) participated in the Lab for All...
Read More
General Announcements
𝐅𝐈𝐆𝐔𝐑𝐄𝐒 𝐈𝐍 𝐅𝐎𝐂𝐔𝐒
20 April 2026
𝘞𝘩𝘢𝘵 𝘮𝘢𝘬𝘦𝘴 𝘦𝘷𝘦𝘳𝘺 𝘯𝘶𝘮𝘣𝘦𝘳 𝘤𝘰𝘶𝘯𝘵? The FDA Verification Portal reflects 𝟐,𝟑𝟏𝟑 𝐕𝐀𝐓-𝐞𝐱𝐞𝐦𝐩𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬, capturing real-time updates as entries are...
Read More
General Announcements
𝐅𝐃𝐀 𝐀𝐓 𝐋𝐈𝐏𝐀 𝐁𝐔𝐒𝐈𝐍𝐄𝐒𝐒 𝐅𝐎𝐑𝐔𝐌: 𝐒𝐔𝐏𝐏𝐎𝐑𝐓𝐈𝐍𝐆 𝐌𝐒𝐌𝐄𝐒 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐂𝐎𝐌𝐏𝐋𝐈𝐀𝐍𝐂𝐄
20 April 2026
In line with the commitment of Director General Paolo S. Teston to empower Micro, Small and Medium Enterprises (MSMEs) and...
Read More
General Announcements
𝐒𝐓𝐑𝐈𝐂𝐓 𝐀𝐂𝐓𝐈𝐎𝐍 𝐓𝐀𝐊𝐄𝐍
20 April 2026
𝘏𝘰𝘸 𝘧𝘢𝘳 𝘤𝘢𝘯 𝘦𝘯𝘧𝘰𝘳𝘤𝘦𝘮𝘦𝘯𝘵 𝘨𝘰 𝘸𝘩𝘦𝘯 𝘷𝘪𝘨𝘪𝘭𝘢𝘯𝘤𝘦 𝘭𝘦𝘢𝘥𝘴 𝘵𝘩𝘦 𝘸𝘢𝘺? In the first quarter of 2026, a total of ₱𝟔,𝟔𝟎𝟎,𝟎𝟎𝟎.𝟎𝟎...
Read More
Academy Training Schedule
Training on Good Manufacturing Practice for Food Manufacturers and Traders (GMP-FMT)
20 April 2026
This webinar will provide the methods, identify the equipment, enumerate the facilities, and determine the controls for producing processed food...
Read More
General Announcements
𝐀𝐓 𝐘𝐎𝐔𝐑 𝐒𝐄𝐑𝐕𝐈𝐂𝐄
15 April 2026
𝘏𝘰𝘸 𝘢𝘤𝘤𝘦𝘴𝘴𝘪𝘣𝘭𝘦 𝘪𝘴 𝘍𝘋𝘈 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘸𝘩𝘦𝘯 𝘪𝘵 𝘮𝘢𝘵𝘵𝘦𝘳𝘴 𝘮𝘰𝘴𝘵? More than you might think. Throughout December 2025 to March 2026,...
Read More
General Announcements
𝐖𝐇𝐄𝐑𝐄 𝐑𝐄𝐅𝐎𝐑𝐌𝐒 𝐁𝐄𝐆𝐈𝐍
15 April 2026
𝘞𝘩𝘢𝘵’𝘴 𝘲𝘶𝘪𝘦𝘵𝘭𝘺 𝘱𝘰𝘸𝘦𝘳𝘪𝘯𝘨 𝘵𝘩𝘦 𝘍𝘋𝘈’𝘴 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯? It’s not just the numbers you see. Behind the scenes, 𝟏𝟓𝟓 𝐬𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫 𝐚𝐧𝐝 𝐨𝐫𝐠𝐚𝐧𝐢𝐳𝐚𝐭𝐢𝐨𝐧𝐚𝐥...
Read More
View More
Latest Advisories
Food Advisories
FDA Advisory No.2026-0434 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION UFC Tropical Punch”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0433 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION Strawberry Watermelon Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0432 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME ICE HYDRATION Red Chill Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0431 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME ICE HYDRATION Orange Flavour”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0430 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYRDATION Goalberry”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0429 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “PRIME HYDRATION Banana Strawberry”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0428 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “POST MARSHMALLOW FRUITY PEBBLES Sweetened Rice Cereal with Marshmallows Natural & Artificial Fruit Flavors”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0427 || The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the unregistered food supplement below:
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0426 || Public Health Warning Against the Purchase and Consumption of the Unregistered Food Product “DR. PINOCA Premium Healthy Rice Low Calories – Low Carb – No Fat”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
Food Advisories
FDA Advisory No.2026-0425 || Public Health Warning Against the Purchase and Consumption of the Unregistered Dietary Supplement “MULITTEA Magnesium Gummies Extra Strength Dietary Supplement”
22 April 2026
The Food and Drug Administration (FDA) warns all healthcare professionals and the general public NOT TO PURCHASE AND CONSUME the...
Read More
View More
Latest Issuances
FDA Circular
FDA Circular No.2025-007 || Guidelines on the Use of the Food and Drug Administration eServices Portal System for the Initial Application of a Certificate of Medical Device Notification (CMDN)
16 December 2025
FDA Circular
FDA Circular No.2025-006 || IMPLEMENTATION OF ONLINE USER ACCOUNT REGISTRATION AND RENEWAL FOR FDA EPORTAL, EPORTAL2, AND RRDPORTAL WITHIN THE FDA ESERVICES PLATFORM
16 December 2025
Administrative Order
Drugs Advisories
Administrative Order No. 2025-0024 || Guidelines in Availing Compassionate Special Permit for the Restricted Use of Covered Pharmaceutical Products and Medical Devices for Human Use
26 November 2025
FDA Circular
FDA Circular No.2025-005 || Delisting of Purchase Booklet from the Checklist of Requirements to Avail of the 20% Senior Citizen Discount on the Purchase of Medicines and Medical Devices in Accordance with the Department of Health Administrative Order No. 2024-0017 Entitled, “Purchase Booklets No Longer Required for the 20% Senior Citizens’ Discount on Medicines, in Compliance with Republic Act No. 9994, Otherwise Known as “The Expanded Senior Citizens Act of 2010””
4 September 2025
FDA Circular
FDA Circular No.2025-004 || Adoption of Codex Standard for Follow-Up Formula for Older Infants and Product/Drink for Young Children (CXS 156-1987) as Technical Regulation
14 July 2025
FDA Circular
FDA Circular No.2025-003 || Adoption of Codex Guidelines for Ready-To-Use Therapeutic Foods (RUTF) (CXG 95-2022) as Technical Regulation
3 July 2025
FDA Circular
DEPARTMENT CIRCULAR NO.2025-0240 || Temporary Suspension for Sixty (60) Working Days of the Implementation of Administrative Order No. 2024-0016 entitled, “Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration”
11 June 2025
FDA Circular
FDA Circular No.2025-002 || Updates and Amendments to the ASEAN Cosmetic Directive (ACD) as Adopted during the 39th ASEAN Cosmetic Committee (ACC) Meeting and Its Related Meetings
18 March 2025
FDA Circular
FDA Circular No.2025-001 || Guidelines on the Classification of Vitamins and Minerals for Food/Dietary Supplements for Adults under Processed Food Product, Repealing the Level Set for Food in the Office Order No. 22 s. 1991 entitled “Guidelines for the Classification of Vitamins and Minerals as Drug or as Food”
7 January 2025
Administrative Order
Administrative Order No. 2024-0016 || Implementing Guidelines on the New Schedule of Fees and Charges of the Food and Drug Administration
3 January 2025
View More
Draft for Comments
Draft for Comments
Draft for Comments || Recognition and Adoption of Official Pharmacopeias for the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients for Human Use
8 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 08 May 2026. I....
Read More
Draft for Comments
Draft for Comments || Amendment to Administrative Order No. 2024-0013 Titled “General Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended for Human Use”
7 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 05 June 2026. I....
Read More
Draft for Comments
Draft for Comments || Amendment to Administrative Order No. 2024-0012 Titled “Prescribing the Rules and Regulations on the Registration of Pharmaceutical Products and Active Pharmaceutical Ingredients Intended Solely for Export”
7 April 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 05 June 2026. I....
Read More
Draft for Comments
Draft for Comments || Good Storage and Distribution Practices for Medical Devices
26 March 2026
All comments can be sent at cdrrhr-prsdd@fda.gov.ph. Deadline of submission of comments shall be by 26 April 2026. I. RATIONALE ...
Read More
Draft for Comments
Draft for Comments || Content of License to Operate (LTO) issued by the Food and Drug Administration for Pharmaceutical Establishments
18 March 2026
All comments can be sent at cdrr.sds@fda.gov.ph. Deadline of submission of comments shall be by 24 April 2026. I. RATIONALE...
Read More
Draft for Comments
Draft for Comments || Use of Official Digital Regulatory Platforms for Issuance of Marketing Authorization for Pharmaceutical Products for Human Use
6 March 2026
All comments may be sent to cdrr.sds@fda.gov.ph using the template provided. The deadline for submission of comments is on 10...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Maintenance of Importation and/or Distribution Records, and the Reporting of Product Complaints, Adverse Events, and Field Safety Corrective Actions for Medical Devices
19 February 2026
All comments can be sent at cdrrhr-prsdd@fda.gov.ph. Deadline of submission of comments shall be by 19 March 2022. I. RATIONALE...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Classification of Deficiencies Observed during the Conduct of Inspection According to Risk, and the Procedure of Compliance of Food Business Operators to the Observed Deficiencies
16 February 2026
All comments can be sent at ojolaurenana@fda.gov.ph. Deadline of submission of comments shall be by March 17, 2026. I. BACKGROUND...
Read More
Draft for Comments
Draft for Comments || Guidelines on the Use of Electronic Services (e-Services) System for the Registration of Processed Food Products Repealing, FDA Circular No. 2020-033 “Procedure for the Use of the Modified Electronic Registration System for Raw Materials and Prepackaged Processed Food Products”
16 February 2026
This draft policy on the FDA e-Services System is an initial working draft and remains subject to ongoing internal review,...
Read More
Draft for Comments
Draft for Comments || Adoption of Codex General Standard for Fruit Juices and Nectars (CXS 247-2005) as Technical Regulation
11 February 2026
All comments shall be sent to gapascual@fda.gov.ph. The deadline for submission of comments is on 03 March 2026. I. RATIONALE In...
Read More
View More
Bids and Awards
ITB and RFQ
SVP(A)-2026-0029-CFRR || Procurement of the Supply and Delivery of Various Collateral Materials for the Celebration of the World Safety Day and Advocacy Campaign (June 2026)
22 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Various Collateral Materials for the Celebration of...
Read More
ITB and RFQ
RFPQ-2026-0027-IMS || Procurement of the “Services of a Certifying Body for the Project: Certification Audit for ISO 9001:2015 Quality Management System (QMS)” of the Food and Drug Administration (FDA))
21 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the "Services of a Certifying Body for the Project: Certification Audit for...
Read More
ITB and RFQ
ITB No. 2026-0019-AFO || Procurement of Security Services for the Food and Drug Administration (FDA) – Alabang Testing and Quality Assurance Laboratory (ATQAL) and Food and Drug Action Center (FDAC) for One (1) Year
21 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Security Services for the Food and Drug Administration (FDA) - Alabang Testing...
Read More
ITB and RFQ
SVP(B)-2026-0020-FDAC || Procurement of Supply, Delivery, and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building
7 April 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply, Delivery, and Installation of Window Blinds for the FDAC, Cashier, and...
Read More
ITB and RFQ
ITB No. 2026-0007-ICMTD || Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet Service and Telephone Subscription for the Food and Drug Administration (FDA) – One Trium Tower for One (1) Year
6 February 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply, Delivery, Installation, Testing and Commissioning of Dedicated 1GBPS (1000MBPS) Bandwidth Internet...
Read More
ITB and RFQ
SVP(A)-2026-0005-FDA-Academy || Procurement for the supply and delivery of the various Collaterals and Training Materials for the Promotion of FDA Academy Trainings/Seminars
5 February 2026
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the supply and delivery of the various Collaterals and Training Materials for...
Read More
ITB and RFQ
NP-SVP-2025-019-MIN || Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of FDA (Per lot)
22 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement for the Supply and Delivery of Parts and Supplies for the vehicles of...
Read More
ITB and RFQ
NP-SVP(A)-2025-0202-FDAC || Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the FDAC, Cashier, and Records Releasing Office on the 8th Floor of Kingston Excell Building
18 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Supply,and Procurement of Supply, Delivery. and Installation of Window Blinds for the...
Read More
ITB and RFQ
NP-SVP(A)-2025-0184-ATQAL REPOST || Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps
12 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of the Supply and Delivery of Laboratory Work Clothes, Footwear and Head Caps...
Read More
ITB and RFQ
NP-SVP(A)-2025-0193-ATQAL REPOST || Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
12 December 2025
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Procurement of Calibration Service for X-ray Multimeter Mondel Unfors X2
Read More
View More
Featured Event
Play
Previous
Next
View More
Featured Activity
Featured Activities
𝐅𝐃𝐀 𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄𝐒 𝐀𝐃𝐕𝐀𝐍𝐂𝐄𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐒𝐀𝐅𝐄𝐓𝐘 𝐀𝐓 𝐒𝐔𝐁𝐈𝐂 𝐁𝐀𝐘 ‘𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋’ 𝐄𝐕𝐄𝐍𝐓
By Administrator 2
/ 26 February 2026
Subic Bay Freeport Zone – On 24 February 2026, the Food and Drug Administration (FDA) Philippines joined the "Lab for...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 “𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐎, 𝐏𝐀𝐑𝐀 𝐊𝐀𝐘 𝐋𝐎𝐋𝐀 𝐂𝐀𝐑𝐀𝐕𝐀𝐍” 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒
By Administrator 3
/ 4 September 2025
As part of its continuing advocacy to reach out to communities, the Food and Drug Administration (FDA), in partnership...
Read More
Featured Activities
Featured Activity || 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐔𝐏𝐏𝐎𝐑𝐓: 𝐅𝐃𝐀’𝐒 𝐑𝐎𝐋𝐄 𝐈𝐍 𝐓𝐇𝐄 𝐌𝐒𝐌𝐄 𝐃𝐄𝐕𝐄𝐋𝐎𝐏𝐌𝐄𝐍𝐓 𝐏𝐋𝐀𝐍 𝟐𝟎𝟐𝟑–𝟐𝟎𝟐𝟖
By Administrator 3
/ 4 September 2025
Baguio City – On 26 August 2025, the Food and Drug Administration (FDA) actively participated in the Department of...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐁𝐑𝐈𝐍𝐆𝐒 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐄𝐑𝐕𝐈𝐂𝐄𝐒 𝐂𝐋𝐎𝐒𝐄𝐑 𝐓𝐎 𝐂𝐎𝐌𝐌𝐔𝐍𝐈𝐓𝐈𝐄𝐒 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐋𝐎𝐂𝐎𝐒 𝐒𝐔𝐑
By Administrator 3
/ 4 September 2025
Candon City, Ilocos Sur – The Food and Drug Administration (FDA) took part in the Lab For All caravan...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐖𝐇𝐎: 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐈𝐍𝐆 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐒𝐘𝐒𝐓𝐄𝐌𝐒 𝐅𝐎𝐑 𝐀 𝐇𝐄𝐀𝐋𝐓𝐇𝐈𝐄𝐑 𝐅𝐔𝐓𝐔𝐑𝐄
By Administrator 3
/ 4 September 2025
Manila City – On 4 August 2025, FDA Director General Paolo S. Teston welcomed Dr. Jinho Shin and Mr....
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐑𝐄𝐀𝐅𝐅𝐈𝐑𝐌𝐒 𝐂𝐎𝐌𝐌𝐈𝐓𝐌𝐄𝐍𝐓 𝐓𝐎 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐕𝐄 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐈𝐎𝐍 𝐀𝐓 𝐋𝐀𝐁 𝐅𝐎𝐑 𝐀𝐋𝐋 𝐈𝐍 𝐒𝐀𝐍 𝐉𝐔𝐀𝐍 𝐂𝐈𝐓𝐘
By Administrator 3
/ 4 September 2025
San Juan City – Last 26 August 2025, the Food and Drug Administration (FDA) participated in the Lab For...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐂𝐇𝐀𝐌𝐏𝐈𝐎𝐍𝐒 𝐇𝐎𝐍𝐄𝐒𝐓 𝐅𝐎𝐎𝐃 𝐋𝐀𝐁𝐄𝐋𝐒 𝐀𝐓 𝐄𝐂𝐂𝐏 𝐍𝐔𝐓𝐑𝐈𝐓𝐈𝐎𝐍 𝐅𝐎𝐑𝐔𝐌 𝟐𝟎𝟐𝟓
By Administrator 3
/ 4 September 2025
Makati City — The Food and Drug Administration (FDA), through its Director General Paolo S. Teston, reaffirmed its commitment...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐃𝐃𝐁 𝐑𝐄𝐈𝐍𝐅𝐎𝐑𝐂𝐄 𝐓𝐇𝐄𝐈𝐑 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐈𝐋𝐈𝐓𝐈𝐄𝐒 𝐀𝐒 𝐏𝐔𝐁𝐋𝐈𝐂 𝐇𝐄𝐀𝐋𝐓𝐇 𝐏𝐀𝐑𝐓𝐍𝐄𝐑𝐒 𝐈𝐍 𝐏𝐑𝐎𝐌𝐎𝐓𝐈𝐍𝐆 𝐑𝐄𝐒𝐏𝐎𝐍𝐒𝐈𝐁𝐋𝐄 𝐔𝐒𝐄 𝐎𝐅 𝐒𝐔𝐁𝐒𝐓𝐀𝐍𝐂𝐄𝐒
By Administrator 3
/ 4 September 2025
Quezon City – On 30 July 2025, the Food and Drug Administration (FDA), headed by Director General Paolo S....
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐒𝐓𝐑𝐄𝐍𝐆𝐓𝐇𝐄𝐍𝐒 𝐋𝐀𝐁𝐎𝐑𝐀𝐓𝐎𝐑𝐘 𝐂𝐎𝐌𝐏𝐄𝐓𝐄𝐍𝐂𝐘 𝐓𝐇𝐑𝐎𝐔𝐆𝐇 𝐒𝐓𝐄𝐑𝐈𝐋𝐈𝐓𝐘 𝐓𝐄𝐒𝐓𝐈𝐍𝐆 𝐓𝐑𝐀𝐈𝐍𝐈𝐍𝐆 𝐖𝐈𝐓𝐇 𝐆𝐋𝐎𝐁𝐀𝐋 𝐄𝐗𝐏𝐄𝐑𝐓𝐒
By Administrator 3
/ 4 September 2025
Alabang, Muntinlupa – As part of its continuing efforts to strengthen regulatory capacity and laboratory competency, the Food and...
Read More
Featured Activities
Featured Activity || 𝐅𝐃𝐀 𝐉𝐎𝐈𝐍𝐒 𝐓𝐇𝐄 𝐍𝐀𝐓𝐈𝐎𝐍𝐀𝐋 𝐌𝐒𝐌𝐄 𝐖𝐄𝐄𝐊 𝐂𝐄𝐋𝐄𝐁𝐑𝐀𝐓𝐈𝐎𝐍
By Administrator 3
/ 4 September 2025
Pasay City – In celebration of National MSME Week 2025, with the theme “Asenso Negosyo, Angat Kabuhayan: Bagong Pilipinas,”...
Read More
View More
Featured Video
Play
Play
Play
Play
Play
Play
Play
Play
Play
Play
Play
Previous
Next
Press Statements
Press Statement
𝐏𝐇𝐈𝐋𝐈𝐏𝐏𝐈𝐍𝐄 𝐅𝐃𝐀 𝐀𝐍𝐃 𝐉𝐀𝐏𝐀𝐍 𝐏𝐌𝐃𝐀 𝐈𝐍𝐒𝐓𝐈𝐓𝐔𝐓𝐈𝐎𝐍𝐀𝐋𝐈𝐙𝐄 𝐒𝐂𝐈𝐄𝐍𝐂𝐄-𝐁𝐀𝐒𝐄𝐃 𝐑𝐄𝐆𝐔𝐋𝐀𝐓𝐎𝐑𝐘 𝐑𝐄𝐋𝐈𝐀𝐍𝐂𝐄 𝐅𝐑𝐀𝐌𝐄𝐖𝐎𝐑𝐊 𝐔𝐍𝐃𝐄𝐑 𝐁𝐈𝐋𝐀𝐓𝐄𝐑𝐀𝐋 𝐂𝐎𝐎𝐏𝐄𝐑𝐀𝐓𝐈𝐎𝐍 𝐌𝐄𝐂𝐇𝐀𝐍𝐈𝐒𝐌
13 February 2026
Manila, Philippines — On 12 February 2026, the Food and Drug Administration Philippines (FDA) and the Pharmaceuticals and Medical Devices...
Read More
Press Statement
PRESS RELEASE || FDA CONDUCTS COORDINATED VERIFICATION VISITS NATIONWIDE TO PROTECT CONSUMERS
6 February 2026
Taguig City - Today, 6 February 2026, the Food and Drug Administration (FDA) conducted coordinated compliance verification visits to selected...
Read More
Press Statement
FDA Press Statement || FDA STATEMENT ON THE VOLUNTARY RECALL OF SELECT INFANT FORMULA PRODUCTS
12 January 2026
The Food and Drug Administration (FDA) informs the public that it is actively overseeing and validating the voluntary recall initiated...
Read More
Press Statement
FDA Press Statement || FDA Reaffirms Commitment to Strengthening Transparency and Efficiency
3 June 2025
Alabang, Muntinlupa City — The Food and Drug Administration (FDA), following the initiative of Director General Paolo S. Teston,...
Read More
Press Statement
FDA Press Statement || FDA Actively Participates During the 2025 USP Convention
3 June 2025
Washington D.C., U.S.A. — To strengthen its global commitment to pharmaceutical excellence and public health, the Food and Drug...
Read More
Press Statement
FDA Press Statement || FDA Director General Urges Suspension of New Regulatory Fees
29 May 2025
Quezon City — The Food and Drug Administration (FDA) urges the Department of Health to approve the immediate suspension...
Read More
Press Statement
FDA Press Statement || DOH USEC. ATTY. PAOLO S. TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCY’S SERVICE TO THE NATION
15 May 2025
Alabang, Muntinlupa City — May 13, 2025 The Food and Drug Administration (FDA) of the Philippines welcomed its...
Read More
Press Statement
FDA Press Statement || FDA Addresses Regulatory Concerns and Promotes Streamlined Processes in PAPPI Seminar
23 April 2025
The Food and Drug Administration (FDA) actively participated in the 1st Quarter Seminar of the Philippine Association of Pharmacists in...
Read More
Press Statement
FDA Press Statement || FDA PARTNERS WITH BICOL SUCs TO BOOST MSME GROWTH
23 April 2025
The Food and Drug Administration (FDA) has actively collaborated with State Universities and Colleges (SUCs) in the Bicol Region...
Read More
Press Statement
FDA Press Statement || FDA Joins LAB for ALL Program in Teresa, Rizal
23 April 2025
The Food and Drug Administration (FDA), under the leadership of Director General Dr. Samuel A. Zacate, reaffirmed its continued...
Read More
View More
Quick Links
Contact Information
Department of Health (DOH)
Department of Information and Communications Technology (DICT)
Department of Science and Technology (DOST)
Anti-Red Tape Authority (ARTA)
Address:
Civic Drive Filinvest Corporate City
Alabang, Muntinlupa City
info@fda.gov.ph
Landline:
(02)-8257-1957
(02)-8286-6087
(02)-8273-0481
(02)-8800-4392
(02)-8273-3756
(02)-8659-7330
Copyright ⓒ 2026. All Rights Reserved.
Copyright ⓒ 2026. All Rights Reserved.
Shares